Studies have suggested that T lymphocyte subsets may change significantly in patients with end-stage renal disease, with significantly reduced levels of CD3+, CD4+, and CD8+T lymphocytes [16]. The gene discussed is CD4; the disease is stage 5 chronic kidney disease.